Salt Lake City-based Cimarron Healthcare Capital (CHC) has acquired a majority equity position in Infusion Management, a management services organization (MSO) that owns infusion therapy company Infusion for Health. Located in Thousand Oaks, California, Infusion for Health treats patients with multiple sclerosis, rheumatoid arthritis and other autoimmune and immunodeficiency disorders in the Greater Los Angeles area.
CHC is a private equity firm focused on healthcare investments in the lower middle market. Financial terms of the transaction were not disclosed.
“Infusion Management and Infusion for Health continue to deliver significant growth through best-in-class customer experience to patients and referring physicians, and significant value to payers as the lowest-cost venue of care,” said James Nadauld, managing partner at CHC. “We could not have found better partners than (Infusion CEO) Clara (Kriger) and her team as we work with (Infusion medical director) Dr. (Michael) Tahery and Infusion for Health to expand the practice.”
“We started Infusion Management with a simple vision: to partner with infusion therapy clinicians in order to provide the highest-quality, most convenient and lowest-cost treatments so patients can continue living their fullest lives,” said Kriger. “Infusion Management will now be in a position to leverage Cimarron’s experience and capabilities to become the premier infusion therapy MSO servicing not only the Greater Los Angeles market, but the entire West Coast. In a crowded landscape of sophisticated healthcare investors, Cimarron’s experience, insights and humility stood out and we are looking forward to working closely with them as we execute on our shared vision for growth.”